메뉴 건너뛰기




Volumn 94, Issue 12, 2004, Pages 1486-1490

Clinical characteristics of persistent lone atrial fibrillation in the RACE study

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; SOTALOL;

EID: 13944267153     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.08.024     Document Type: Article
Times cited : (22)

References (23)
  • 1
    • 0027245716 scopus 로고
    • Atrial arrhythmias
    • F.D. Murgatroyd, A.J. Camm Atrial arrhythmias Lancet 341 1993 1317 1322
    • (1993) Lancet , vol.341 , pp. 1317-1322
    • Murgatroyd, F.D.1    Camm, A.J.2
  • 2
    • 2542507510 scopus 로고    scopus 로고
    • Characterization of different subsets of atrial fibrillation in general practice in France: The ALFA study: The College of French Cardiologists
    • S. Levy, M. Maarek, P. Coumel, L. Guize, J. Lekieffre, J.L. Medvedowsky, A. Sebaoun Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study The College of French Cardiologists Circulation 99 1999 3028 3035
    • (1999) Circulation , vol.99 , pp. 3028-3035
    • Levy, S.1    Maarek, M.2    Coumel, P.3    Guize, L.4    Lekieffre, J.5    Medvedowsky, J.L.6    Sebaoun, A.7
  • 3
    • 84960994165 scopus 로고
    • Lone auricular fibrillation
    • W. Evans, P. Swann Lone auricular fibrillation Br Heart J 16 1954 189 194
    • (1954) Br Heart J , vol.16 , pp. 189-194
    • Evans, W.1    Swann, P.2
  • 5
  • 6
    • 0028889583 scopus 로고
    • Clinical course of lone atrial fibrillation since first symptomatic arrhythmic episode
    • C. Rostagno, F. Bacci, M. Martelli, A. Naldoni, G. Bertini, G. Gensini Clinical course of lone atrial fibrillation since first symptomatic arrhythmic episode Am J Cardiol 76 1995 837 839
    • (1995) Am J Cardiol , vol.76 , pp. 837-839
    • Rostagno, C.1    Bacci, F.2    Martelli, M.3    Naldoni, A.4    Bertini, G.5    Gensini, G.6
  • 7
    • 0032911217 scopus 로고    scopus 로고
    • Lone atrial fibrillation: Prognostic differences between paroxysmal and chronic forms after 10 years of follow-up
    • S. Scardi, C. Mazzone, C. Pandullo, D. Goldstein, A. Poletti, F. Humar Lone atrial fibrillation: prognostic differences between paroxysmal and chronic forms after 10 years of follow-up Am Heart J 137 1999 686 691
    • (1999) Am Heart J , vol.137 , pp. 686-691
    • Scardi, S.1    Mazzone, C.2    Pandullo, C.3    Goldstein, D.4    Poletti, A.5    Humar, F.6
  • 9
    • 0022371842 scopus 로고
    • Characteristics and prognosis of lone atrial fibrillation: 30-year follow-up in the Framingham Study
    • F.N. Brand, R.D. Abbott, W.B. Kannel, P.A. Wolf Characteristics and prognosis of lone atrial fibrillation: 30-year follow-up in the Framingham Study JAMA 254 1985 3449 3453
    • (1985) JAMA , vol.254 , pp. 3449-3453
    • Brand, F.N.1    Abbott, R.D.2    Kannel, W.B.3    Wolf, P.A.4
  • 10
    • 0033020913 scopus 로고    scopus 로고
    • Idiopathic atrial fibrillation as a risk factor for mortality: The Paris Prospective Study I
    • X. Jouven, M. Desnos, C. Guerot, P. Ducimetiere Idiopathic atrial fibrillation as a risk factor for mortality The Paris Prospective Study I Eur Heart J 20 1999 896 899
    • (1999) Eur Heart J , vol.20 , pp. 896-899
    • Jouven, X.1    Desnos, M.2    Guerot, C.3    Ducimetiere, P.4
  • 11
    • 0034715973 scopus 로고    scopus 로고
    • Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): A randomised trial
    • S.H. Hohnloser, K.H. Kuck, J. Lilienthal Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial Lancet 356 2000 1789 1794
    • (2000) Lancet , vol.356 , pp. 1789-1794
    • Hohnloser, S.H.1    Kuck, K.H.2    Lilienthal, J.3
  • 14
    • 0038025290 scopus 로고    scopus 로고
    • Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: The Strategies of Treatment of Atrial Fibrillation (STAF) study
    • J. Carlsson, S. Miketic, J. Windeler, A. Cuneo, S. Haun, S. Micus, S. Walter, U. Tebbe Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study J Am Coll Cardiol 41 2003 1690 1696
    • (2003) J Am Coll Cardiol , vol.41 , pp. 1690-1696
    • Carlsson, J.1    Miketic, S.2    Windeler, J.3    Cuneo, A.4    Haun, S.5    Micus, S.6    Walter, S.7    Tebbe, U.8
  • 15
    • 0037028043 scopus 로고    scopus 로고
    • Management of atrial fibrillation--radical reform or modest modification?
    • R.H. Falk Management of atrial fibrillation--radical reform or modest modification? N Engl J Med 347 2002 1883 1884
    • (2002) N Engl J Med , vol.347 , pp. 1883-1884
    • Falk, R.H.1
  • 17
    • 0019435542 scopus 로고
    • Mortality in an insured population with atrial fibrillation
    • J. Gajewski, R.B. Singer Mortality in an insured population with atrial fibrillation JAMA 245 1981 1540 1544
    • (1981) JAMA , vol.245 , pp. 1540-1544
    • Gajewski, J.1    Singer, R.B.2
  • 20
    • 0027965628 scopus 로고
    • Anticoagulation in atrial fibrillation: Does efficacy in clinical trials translate into effectiveness in practice?
    • L.K. Gottlieb, S. Salem-Schatz Anticoagulation in atrial fibrillation Does efficacy in clinical trials translate into effectiveness in practice? Arch Intern Med 154 1994 1945 1953
    • (1994) Arch Intern Med , vol.154 , pp. 1945-1953
    • Gottlieb, L.K.1    Salem-Schatz, S.2
  • 22
    • 0345414673 scopus 로고    scopus 로고
    • Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): Randomised controlled trial
    • S.B. Olsson Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial Lancet 362 2003 1691 1698
    • (2003) Lancet , vol.362 , pp. 1691-1698
    • Olsson, S.B.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.